home / stock / entbf / entbf quote
Last: | $0.1389 |
---|---|
Change Percent: | -25.14% |
Open: | $0.1389 |
Close: | $0.1389 |
High: | $0.1389 |
Low: | $0.1389 |
Volume: | 314 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1389 | $0.1389 | $0.1389 | $0.1389 | $0.1389 | 314 | 05-02-2024 |
$0.111 | $0.111 | $0.111 | $0.111 | $0.111 | 115 | 05-01-2024 |
$0.1371 | $0.1371 | $0.1371 | $0.1371 | $0.1371 | 160 | 04-30-2024 |
$0.1159 | $0.1159 | $0.1159 | $0.1159 | $0.1159 | 100 | 04-29-2024 |
$0.14436 | $0.115 | $0.14436 | $0.14436 | $0.115 | 5,760 | 04-26-2024 |
$0.121 | $0 | $0.121 | $0 | $0 | 85 | 04-25-2024 |
$0.121 | $0.121 | $0.121 | $0.121 | $0.121 | 170 | 04-24-2024 |
$0.115 | $0.13153 | $0.115 | $0.13153 | $0.115 | 739 | 04-23-2024 |
$0.1138 | $0 | $0.1138 | $0 | $0 | 70 | 04-22-2024 |
$0.1138 | $0.1138 | $0.1138 | $0.1138 | $0.1138 | 500 | 04-19-2024 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 10,000 | 04-18-2024 |
$0.1102 | $0.1102 | $0.1102 | $0.1102 | $0.1102 | 14,000 | 04-16-2024 |
$0.11992 | $0.079 | $0.11992 | $0.11992 | $0.079 | 2,426 | 04-15-2024 |
$0.0769 | $0 | $0.0769 | $0 | $0 | 61 | 04-12-2024 |
$0.0769 | $0 | $0.0769 | $0 | $0 | 40 | 04-11-2024 |
$0.0769 | $0 | $0.0769 | $0 | $0 | 12 | 04-10-2024 |
$0.0769 | $0 | $0.0769 | $0 | $0 | 51 | 04-09-2024 |
$0.0769 | $0 | $0.0769 | $0 | $0 | 5 | 04-08-2024 |
$0.0769 | $0.11935 | $0.0769 | $0.11935 | $0.0769 | 8,338 | 04-04-2024 |
$0.114 | $0.13122 | $0.114 | $0.13122 | $0.114 | 21,760 | 04-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
Entheon Biomedical Corp Com Company Name:
ENTBF Stock Symbol:
OTCMKTS Market:
2024-03-27 17:08:02 ET Addiction is an issue that affects a significant number of people worldwide. While conventional treatments have existed for decades, they offer a very low rate of efficacy, often as low as 5%. For Timothy Ko , CEO of Entheon Biomedical , the problem ...
2024-03-27 17:08:02 ET Leading-edge addiction recovery solution Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorde...
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) , a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fel...